76979-32-3

Upstream product

• 6318-36-1 (E,Z)-5-(2-chlorophenylmethylene)-4-oxo-2-thioxothiazolidine 
• 77-78-1 dimethyl sulfate 
• 74-88-4 methyl iodide 
• 89-98-5 2-chloro-benzaldehyde 

Downstream Products

• 36937-41-4 5-(2-chlorophenylmethylene)-2-piperidino-4-oxo-2-thiazoline 
• 76979-46-9 5-(2-Chlorophenylmethylene)-2-(4-methoxyphenylmethylimino)-4-thiazolidinone 
• 76979-44-7 5-(2-chlorophenylmethylene)-2-(4-methylphenylmethylimino)-4-oxothiazolidine 
• 76979-42-5 5-(2-Chlorophenylmethylene)-2-(phenylmethylimino)-4-thiazolidinone 
• 36946-73-3 5-(2-Chlorophenylmethylene)-2-imino-4-thiazolidinone 
• 98949-12-3 (Z)-5-(2-chlorobenzylidene)-thiazolidin-2,4-dione 
• 36937-48-1 5-(2-chlorophenylmethylene)-2-morpholino-4-oxo-2-thiazoline 

Relevant academic research and scientific papers

Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors

Abstract A type of novel rhodanine-based 4-anilinoquinazoline, which designed the combination between quinazoline as the backbone and various substituted biological rhodanine groups as the side chain, have been synthesized, and their antiproliferative act